CMOs Face Capacity Challenges, Talent Shortages As Pandemic Increases Demand For Their Services
The need for more plant capacity, process scale-up and skilled workers are major challenges cited by a CMO in producing clinical trial materials for COVID-19 vaccines. Recent white paper says 70% of manufacturers expect to outsource activities due to pandemic.
You may also be interested in...
The WHO proposes to revise 2011 guidance on technology transfers to ease the hand-off of COVID-19 drugs and vaccines from research and development facilities to commercial sites.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
The UK's MHRA has granted an emergency authorization to the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.